A novel umbrella review was conducted to assess the efficacy and safety of GLP-1 RAs in MASLD in multiple dimensions
The approval also does not change insurance coverage policies, which vary by plan and often exclude weight management medications
Among the 47.5 million Medicare Part D enrollees in 2023, 9.7 million enrollees met the clinical criteria for the Medicare GLP-1 Bridge in 2023, but less than half of this group3.8 million (39%)is estimated to be eligible for Bridge (Figure 2, Table 1)
doi: 10.1212/CON.0000000000001103 [PubMed] 35449037 Bilbao-Meseguer I, Barrasa H, Rodrguez-Gascn A, Asn-Prieto E, Maynar J, Snchez-Izquierdo J, Solins M, Isla A
5b), while the OD for diarrhea was 0.70 (95% CI 0.22 to 2.23) from four studies (Fig
The convenience, the education, and the professionalism were top-tier